Work

A Simple Schema for Informed Decision Making About Prostate Cancer Screening

Year: 2014

Type: editorial

Abstract: Screening for prostate cancer with prostate-specific anti-gen (PSA) testing is a problematic aspect of primary care. With the exception of the U.S. Preventive Services Task Force, which made an influential (1) but highly crit-icized (2) recommendation against any early detection ef-forts based on PSA testing, most organizations recommend that an informed decision be made by the patient after discussion with a physician. For example, the American College of Physicians is generally skeptical of the benefits of PSA testing (“for most... men, the harms will out-weigh the benefits”) but recommends that “doctors and patients should discuss the potential benefits and harms of screening ” (3, 4). Similarly, the American Urological Asso-ciation, although more favorably disposed to screening, “strongly recommend[s] shared decision-making ” (5). Implementing shared decision making in primary care

Source: Annals of Internal Medicine

DOI: 10.7326/m14-0151

Authors: Andrew J. Vickers, Kelly Edwards, Matthew R. Cooperberg, Alvin I. Mushlin

Institutions: Memorial Sloan Kettering Cancer Center, University of California, San Francisco, University of Washington, UCSF Helen Diller Family Comprehensive Cancer Center, Cornell University

Language: English

Topic: Prostate Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Center for Research Resources, National Center for Chronic Disease Prevention and Health Promotion